Compare CNS & RDNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNS | RDNT |
|---|---|---|
| Founded | 1986 | 1985 |
| Country | United States | United States |
| Employees | 424 | N/A |
| Industry | Investment Managers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.6B |
| IPO Year | 2004 | 1996 |
| Metric | CNS | RDNT |
|---|---|---|
| Price | $78.08 | $65.55 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $71.50 | ★ $82.80 |
| AVG Volume (30 Days) | 309.1K | ★ 948.2K |
| Earning Date | 04-16-2026 | 05-11-2026 |
| Dividend Yield | ★ 3.96% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.82 | N/A |
| Revenue | $427,536,000.00 | ★ $1,616,630,000.00 |
| Revenue This Year | $4.71 | $22.78 |
| Revenue Next Year | $4.37 | $10.70 |
| P/E Ratio | $93.78 | ★ N/A |
| Revenue Growth | 4.07 | ★ 13.05 |
| 52 Week Low | $58.39 | $50.79 |
| 52 Week High | $80.48 | $85.84 |
| Indicator | CNS | RDNT |
|---|---|---|
| Relative Strength Index (RSI) | 57.46 | 63.16 |
| Support Level | $59.88 | $64.71 |
| Resistance Level | $78.69 | $74.55 |
| Average True Range (ATR) | 2.10 | 2.71 |
| MACD | -0.11 | 0.60 |
| Stochastic Oscillator | 65.68 | 72.90 |
Cohen & Steers is a niche asset manager concentrating on real estate securities. The firm invests primarily in the equity shares of real estate investment trusts, with holdings in domestic and international real estate securities accounting for nearly two-thirds of its $99.5 billion in managed assets at the end of May 2026. Cohen & Steers also manages portfolios dedicated to preferred securities, utilities stocks, and other high-yield offerings. The firm's distribution is balanced among its closed-end funds, open-end funds, and institutional accounts. During the past four calendar quarters, the company garnered 39% (25%) of its managed assets (base management fees) from institutional clients, 48% (55%) from open-end funds, and 13% (20%) from closed-end funds.
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.